St. Jude Maps Alzheimer's Proteins Across Brain Cells

A cell-type-specific protein atlas published in Neuron identifies thousands of proteins whose levels shift in Alzheimer's disease.

Updated on Nov. 18, 2026 in Alzheimer’s

Photograph of a benchtop mass spectrometry instrument beside a tray of pale amber tissue sections in a clean research laboratory.
Researchers at St. Jude Children's Research Hospital published a protein atlas in Neuron identifying over 3,000 proteins whose levels shift in Alzheimer's disease. AI Illustration. Upload story photo >

Scientists at St. Jude Children's Research Hospital published a cell-type-specific protein atlas of Alzheimer's disease in Neuron. The atlas identified over 3,000 proteins with altered levels across cell types, 78% of which had not been captured before.

Why it matters

Alzheimer's disease can affect almost the entire brain, yet how different cell types are specifically affected has not been fully understood. The atlas gives researchers a map of candidate disease drivers that can be examined in future follow-up studies.

The study profiled over 13,000 proteins across multiple ages and cell types in two mouse models, with 78% of the over 3,000 altered proteins previously uncaptured. Whether these changes occur in the same way in human patients has not yet been established.

The players

St. Jude Children's Research Hospital

A Memphis, Tennessee pediatric research and treatment hospital founded in 1962 by entertainer Danny Thomas and known for its biomedical research.

The details

The team combined next-generation mass spectrometry with single-cell RNA sequencing and spatial omics, then compared the proteomic data directly with single-cell RNA data from the two mouse models. Almost all changes to microglia were previously undetected, and the approach uncovered a potential communication network between cell types; for example, the protein pleiotrophin showed high RNA levels in astrocytes and high protein levels in microglia.

Timeline

  1. November 18, 2026: Findings published in Neuron.

Health Landscape

The atlas extends single-cell RNA sequencing work in Alzheimer's mouse models by adding protein-level measurements that transcript data alone cannot reveal. It moves the field closer to the single-cell analysis of human Alzheimer's samples that the authors say the atlas will enable.

The findings are early-stage laboratory research in mice and do not change current treatment or diagnosis for patients. The proteins identified may eventually inform new therapeutic targets, but that remains a future possibility.

The takeaway

Mapping disease changes cell by cell may reveal which specific brain cells to target in future research. Readers following Alzheimer's research should watch for follow-up studies testing these proteins in human samples.

Further reading

For more on the disease itself, see our Alzheimer's coverage.

More information

Explore the Alzheimer's cell-type protein atlas and datasets that accompany the study.